Clinical Trials
2 trialsNCT07239102 2025-11-20
Firmonertinib in the Treatment of EGFR(+) NSCLC Patients With Central Nervous System Metastasis
Beijing Tiantan Hospital
Completed
NCT02071056 2020-08-18
Circulating Tumor DNA in Cerebrospinal Fluid as an Early Biomarker of Leptomeningeal Metastasis (LM)
Dartmouth-Hitchcock Medical Center
Completed